Effectiveness of different treatments in obesity hypoventilation syndrome.
Bariatric Surgery
/ adverse effects
Body Mass Index
Cardiometabolic Risk Factors
Case-Control Studies
Comparative Effectiveness Research
/ statistics & numerical data
Continuous Positive Airway Pressure
/ methods
Cost-Benefit Analysis
Early Diagnosis
Humans
Obesity
/ complications
Obesity Hypoventilation Syndrome
/ diagnosis
Oxygen Inhalation Therapy
/ methods
Polysomnography
/ methods
Prevalence
Quality of Life
Rehabilitation
/ methods
Sleep Apnea Syndromes
/ diagnosis
Weight Loss
/ physiology
CPAP
Hypoventilation
Obesity
Positive airway therapy
Sleep apnea
Journal
Pulmonology
ISSN: 2531-0437
Titre abrégé: Pulmonology
Pays: Spain
ID NLM: 101723786
Informations de publication
Date de publication:
Historique:
received:
14
05
2020
accepted:
15
05
2020
pubmed:
20
6
2020
medline:
28
7
2021
entrez:
20
6
2020
Statut:
ppublish
Résumé
Obesity hypoventilation syndrome (OHS) is an undesirable consequence of obesity, defined as daytime hypoventilation, sleep disorder breathing and obesity; during the past few years the prevalence of extreme obesity has markedly increased worldwide consequently increasing the prevalence of OHS. Patients with OHS have a lower quality of life and a higher risk of unfavourable cardiometabolic consequences. Early diagnosis and effective treatment can lead to significant improvement in patient outcomes; therefore, such data has noticeably raised interest in the management and treatment of this sleep disorder. This paper will discuss the findings on the main current treatment modalities OHS will be discussed.
Identifiants
pubmed: 32553827
pii: S2531-0437(20)30128-8
doi: 10.1016/j.pulmoe.2020.05.012
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
370-377Informations de copyright
Copyright © 2020 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved.